# POTASSIUM CITRATE
> **ANDA212799** · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2020-06-29
## Drug
- **FDA Application Number:** ANDA212799
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM CITRATE
- **Generic name:** Potassium Citrate
- **Active ingredients:** POTASSIUM CITRATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BIONPHARMA
- **First approval:** 2020-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212799)
---
*AI Analytics · CC0 1.0*